Not to mention there's another bio on the OTC currently in 5 ACTIVE clinical trials at reputable locations. They have a lot of uncertainty and have been bashed a ton but yet they move forward.
All that matters is three things: cold hard cash, the right management and a marketable useful product that works.
Now PMCB doesn't have the former. All that BS pump n dump Waggoner talked about how it was not relevant being funded is BS. They are going to need a lot more money to do anything. It's that simple.
Ken Waggoner coming from the worst pump n dump this millennium means, for me, I won't ever trust anything he ever says. It's just that simple. He has been down in the mud for far too long at retail shareholder expense.
The Austrianova doctors? I've never been impressed. As far as I can tell they have never accomplished much of anything, but have spent most of the past 20 years trying to pump Cell in a Box without it ever helping one person with cancer. 20 years. One works at a veterinary college, the others are relegated to Asia.
Times have changed and bio is onto more advanced therapies beyond chemo based treatments. PMCB has garnered ZERO interest from big pharma and large investors. Again, Ken Waggoner, VelaTel ChinaTel executive is talking BS because he has been blowing CiAB for years now, been touting his presence at conferences, stating interest this and that, and it has amounted to nothing
CiAB isnt new, it hasn't just hit the market. The entire bio world has had a chance to look at it for the past 15 years after it was dropped by Bavarian.
Never trust anything a small cap bio CEO says. And certainly never when it's on the OTC.
Money
A good product
the brains to push it through...
idk
Caveat Emptor
News 
Market Data 
Discover 
